Carlo Sansalone
Net worth: 57 200 $ as of 31/07/2026
Net worth: 57 200 $ as of 31/07/2026
Carlo Sansalone is President & Director at Sanscon Construction Ltd. since 1999.
Mr. Sansalone is Independent Director at Pharmather Holdings Ltd. since 2020.
Former roles include Independent Director at Mercury Capital II Ltd., Independent Director at Revive Therapeutics Ltd. from 2014 to 2019, and Independent Non-Executive Director at DiagnaMed Holdings Corp.
from 2023 to 2025.
Education includes an undergraduate degree from Toronto Metropolitan University, conferred in 2000.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/07/2025 | 1,300,000 ( 1.43% ) | 57 200 $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| PHARMATHER HOLDINGS LTD. | Director/Board Member | 01/06/2020 |
Sanscon Construction Ltd.
Sanscon Construction Ltd. Engineering & ConstructionIndustrial Services Provides engineering and construction services | President | 01/01/1999 |
| Companies | Position | End |
|---|---|---|
| DIAGNAMED HOLDINGS CORP. | Director/Board Member | 02/07/2025 |
| REVIVE THERAPEUTICS LTD. | Director/Board Member | 18/12/2019 |
Mercury Capital II Ltd.
Mercury Capital II Ltd. Financial ConglomeratesFinance Operates as a capital pool company | Director/Board Member | 08/01/2014 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Mercury Capital II Ltd.
Mercury Capital II Ltd. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Toronto Metropolitan University of
Toronto Metropolitan University of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanscon Construction Ltd.
Sanscon Construction Ltd. Engineering & ConstructionIndustrial Services Provides engineering and construction services | Industrial Services |
Revive Therapeutics Ltd.
Revive Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in acquiring, developing, and commercializing therapeutic products | Health Technology |
PharmaTher Holdings Ltd.
PharmaTher Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops psychedelic pharmaceuticals | Health Technology |
DiagnaMed Holdings Corp.
DiagnaMed Holdings Corp. BiotechnologyHealth Technology Engages in development and commercialization of digital therapeutics for people suffer from mental health and neurological disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions